Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

Amedeo Lonardo¹, Fabio Nascimbeni^{2

3}, Maurizio Ponz de Leon^{2

3}

Affiliations

¹ Operating Unit of Internal Medicine, OCSAE, Modena, Italy a.lonardo@libero.it.
² Operating Unit of Internal Medicine, OCSAE, Modena, Italy.
³ University of Modena and Reggio Emilia, Modena, Italy.

Free article

Editorial

Amedeo Lonardo et al. Eur Respir J. 2017.

Free article

. 2017 Jun 8;49(6):1700546.

doi: 10.1183/13993003.00546-2017. Print 2017 Jun.

Amedeo Lonardo¹, Fabio Nascimbeni^{2

3}, Maurizio Ponz de Leon^{2

3}

¹ Operating Unit of Internal Medicine, OCSAE, Modena, Italy a.lonardo@libero.it.
² Operating Unit of Internal Medicine, OCSAE, Modena, Italy.
³ University of Modena and Reggio Emilia, Modena, Italy.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.
Viglino D, Jullian-Desayes I, Minoves M, Aron-Wisnewsky J, Leroy V, Zarski JP, Tamisier R, Joyeux-Faure M, Pépin JL. Viglino D, et al. Eur Respir J. 2017 Jun 8;49(6):1601923. doi: 10.1183/13993003.01923-2016. Print 2017 Jun. Eur Respir J. 2017. PMID: 28596431